Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma Patients
Condition(s):Colorectal Adenocarcinoma; OesogastricLast Updated:September 18, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Colorectal Adenocarcinoma; OesogastricLast Updated:September 18, 2023Terminated
Condition(s):Metastatic Colorectal CancerLast Updated:March 1, 2024Active, not recruiting
Condition(s):Metastatic Colorectal CancerLast Updated:January 8, 2024Not yet recruiting
Condition(s):First-line Treatment; Advanced Colorectal CancerLast Updated:October 25, 2021Recruiting
Condition(s):Gastric and Gastroesophageal Junction AdenocarcinomaLast Updated:August 19, 2022Not yet recruiting
Condition(s):Metastatic Colorectal CancerLast Updated:February 14, 2024Recruiting
Condition(s):Cholangiocarcinoma; Bile Duct CancerLast Updated:December 1, 2022Terminated
Condition(s):Metastatic Colon CancerLast Updated:February 1, 2024Completed
Condition(s):Metastatic Colorectal CancerLast Updated:November 22, 2021Completed
Condition(s):Locally Advanced Rectal CancerLast Updated:February 22, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.